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Introduction
Metabotropic glutamate receptors (mGluRs), members of the family 3 G protein-coupled receptors (GPCRs), play pivotal roles in the regulation of synaptic plasticity in the cerebellum and hippocampus and in information processing in the retina and olfactory bulb (Ferraguti and Shigemoto, 2006) .
Eight subtypes of mGluRs have been identified and classified into three subgroups based on their sequence similarity, transduction cascade and pharmacology. They exist as constitutive homodimers and possess a large extracellular ligand-binding domain (ECD) on the N-terminal side of a seven-transmembrane domain (TMD). Upon agonist binding, they change the structure of the ECD (Kunishima et al., 2000; Muto et al., 2007; Tsuchiya et al., 2002) , the helical arrangements of the TMD (Brock et al., 2007; Tateyama et al., 2004; Yamashita et al., 2008) and the configuration of the cytoplasmic G protein-interacting site (Francesconi and Duvoisin, 1998; Gomeza et al., 1996; Yamashita et al., 2001) , which eventually leads to the activation of G proteins.
Recently, mGluRs have received much attention as potential drug targets for a wide variety of neurological disorders, and several artificial agonists, antagonists and even allosteric modulators have been generated (Ossowska et al., 2007; Patil et al., 2007) . In particular, allosteric modulators are expected to be superior drugs with small side effects on ionotropic glutamate receptors and also with high selectivity for each mGluR subtype (Marino et al., 2003; May et al., 2007) . Thus, investigation of switch regions in the TMD, which are the potential target sites of allosteric modulators, is of great interest.
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It is generally accepted from the studies on family 1 GPCRs that a constitutively active mutation (CAM) site is one of the "epicenters" of active structural changes in GPCRs (Smit et al., 2007) . In fact, it was reported that several CAM sites present in the transmembrane region in family 1 GPCRs act as an activation switch regulating the equilibrium between inactive and active states (Bakker et al., 2008; Cohen et al., 1993; Decaillot et al., 2003; Huang et al., 2001; Javitch et al., 1997; Kjelsberg et al., 1992; Prioleau et al., 2002) .
Recently, the crystal structures of rhodopsins and adrenergic receptors were revealed by X-ray crystallography studies (Okada et al., 2002; Palczewski et al., 2000; Park et al., 2008; Rasmussen et al., 2007; Rosenbaum et al., 2007; Scheerer et al., 2008) , and provided substantial information about the CAM-induced conformational changes in family 1 GPCRs. Therefore, it can be speculated that if a CAM site is present in the TMD of mGluR, it should function in an activation switch of the TMD and could be a potential target site of allosteric modulators. The current findings clearly showed the presence of several CAM sites in the TMD of mGluR8. In addition, we obtained evidence that the CAM site at position 764 located in helix V forms a specific pair with that at position 663 in helix III. Destruction of this interaction by mutation of the amino acid residue at either site caused an elevation of constitutive activity. The importance of this pair of CAM sites in the TMD will be discussed in relation to the maintenance of the inactive state and the signal flow from the ECD to the cytoplasmic G protein-activating domain.
Preparation of mGluR mutants
Expression of mGluR8 in HEK293S cells was performed by the method previously reported (Yamashita et al., 2008) . In order to detect the expression of mGluRs by immunoblotting analysis, the cDNAs of mGluR were tagged with the epitope sequence of the anti-bovine rhodopsin monoclonal antibody Rho1D4 at the C-terminus. The wild-type and mutant cDNAs of mGluR were introduced into the mammalian expression vector pcDNA3.1 (Invitrogen). HEK293S cells were grown to ~ 40 % confluency in DMEM/F12
supplemented with 10 % fetal bovine serum and were transfected with wild-type or mutant mGluR8 plasmid DNA (10 μg / 100-mm dish) using the calcium-phosphate method. The cells were collected by centrifugation 48 hr after transfection. The cell membranes were homogenized in 50 % sucrose in buffer A [50 mM HEPES (pH 6.5) and 140 mM NaCl] and collected by centrifugation. The supernatant was diluted in two volumes of buffer A and re-centrifuged. The membrane pellets were washed with buffer A and suspended in buffer B [50 mM HEPES (pH 8.0) and 140 mM NaCl, and 3 mM MgCl 2 ] for the ligand binding assay and the GTPγS binding assay.
Ligand binding assay of mGluR8
GTPγS binding assay of mGluR8
The assay of G protein activation by mGluR8 was carried out according to our previous report (Yamashita et al., 2008) . The mGluR8-expressing membranes (final concentration, 2 nM) after sucrose flotation were suspended in 0.03 % dodecylmaltoside (DM) in buffer C This article has not been copyedited and formatted. The final version may differ from this version. 
Immunoblotting
Wild-type and mGluR mutants were detected with the Rho1D4 monoclonal antibody against the tag sequence at the C-terminus. The cell membrane suspension in the buffer described above containing no β-mercaptoethanol was subjected to SDS-PAGE (5.5%), and then transferred onto a polyvinylidene difluoride membrane and probed with Rho1D4
antibody. Immunoreactive proteins were detected by the ABC method and were visualized using the horseradish peroxidase-diaminobenzidine reaction. Visualization was carried out according to (Terakita et al., 1996) .
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Results

Identification of novel CAMs in TMD of mGluR8
In order to search for the key amino acid residues responsible for the structural changes in the TMD of mGluR8, we utilized previously obtained information about the activating mutations identified in the calcium-sensing receptor (CaSR), which also belongs to family 3. More than 30 naturally occurring activating mutations of CaSR have been genetically identified as a cause of autosomal dominant hypocalcemia (Hu and Spiegel, 2003) . These mutations result in a severalfold increase of sensitivity to Ca 2+ or elevation of the constitutive activity of CaSR (Hu et al., 2005) . We expected that some of these mutation sites would also be involved in the activation of other family 3 GPCRs.
We therefore introduced amino acid substitutions that caused modification of the CaSR phenotype into the corresponding positions of mGluR8 according to their sequence alignment (Table 1 , Fig.1 ) (Duvoisin et al., 1995 10/28 mutations (F797L, I798A, I800S, F801A, Y812L and T819E), which are all located in the region connecting helices VI and VII, exhibited a slight elevation of constitutive activity and a decrease of the agonist-induced activity. In contrast, T764C showed remarkably high basal and agonist-induced activities. T764 is located in helix V and is completely conserved in all mGluR subtypes, while the six residues mutated in the connecting region exhibit moderate conservation among mGluR subtypes.
Characterization of mGluR8 T764 Mutants
Reasoning that the characterization of T764 mutants should provide some novel insights about the role of helix V in the activation path of mGluR, next we prepared 19 single-replacement mutants of mGluR8 at this position and investigated their Go activation abilities. Extremely low expression of the functional protein was detected when T764 was substituted with charged amino acids or proline. All the other mutants showed a remarkable increase in constitutive activity, which was monitored by the [ 35 S]GTPγS binding assay (Fig.   2a ). The agonist-induced activities of the mutant proteins were also elevated over the maximal activity of wild-type, but there was no relationship between the level of basal activity and that of agonist-induced activity. More intriguingly, several substitutions (N, Q, Y, W) resulted in a loss of ability to respond to L-AP4.
Because of their high expression levels, we selected T764A and T764W as representative mutants that do and do not respond to agonist, respectively, and analyzed the mutant profiles in more detail.
This article has not been copyedited and formatted. The final version may differ from this version. was constant (Table 2) , T764A exhibited about a 2-fold higher affinity to L-AP4 than the wild-type (Fig. 2b) . In addition, it exhibited a left-shifted EC 50 value in the measurements of L-AP4-dependent Go activation (Fig. 2c) . Like T764A, T764W showed higher affinity to L-AP4, but it exhibited no L-AP4-dependent Go activation. Thus, introduction of a bulky amino acid into the 764 position breaks down the relay of structural changes from ECD to the cytoplasmic region, although it induces a structural change of the ECD that produces a high affinity state.
Identification of Y663 as a partner residue with T764
To understand the detailed mechanism of structural changes around T764, it is necessary to identify the residue(s) interacting with T764. Since all mutations at position 764 resulted in elevation of the basal activity, a mutation at the partner residue should also cause some elevation of basal activity by disturbing the microenvironment constituted by T764 and this partner.
Consequently, we searched for novel CAM sites in other helices by comprehensive alanine-scanning mutagenesis. We introduced alanine mutations into 10 residues in each helix (a total of 60 residues) (Fig. 1) . The original alanine residues were substituted with serine. Then the G protein activation abilities of these mutants were monitored by the [
S]GTPγS binding
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showed an elevation of the basal activity (Fig. 3a) . Competition ligand binding analysis indicated that some of them (Y663A, L667A, M787A and C791A)
showed an increase in affinity to L-AP4, like T764 mutants ( Y663A/ T764W showed lower basal activity than that of the T764W single mutant (Fig. 3b) . In contrast, all the other double mutants exhibited higher basal activity. Furthermore, Y663A/T764W showed recovery of the responsiveness to agonist (Fig. 3c) . These results strongly suggest that Y663 interacts with T764 to form an activation switch in the TMD of mGluR.
We therefore prepared a set of site-directed mutants at position 663 and analyzed their G protein activation abilities in order to obtain more information about the environment around Y663. In the [ 35 S]GTPγS binding assay, 4 mutants (A, S, T, W) showed increases of the constitutive activity (Fig. 3d) .
Especially, introduction of a tryptophan at residue 663 enlarged the side chain volume and markedly increased the activity to a level comparable to that of T764A. Y663W also displayed 2-fold higher affinity to L-AP4 than the wild-type
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To test whether or not other residues are involved in this activation switch, we also analyzed 53 other double mutants combining T764W and alanine mutations that did not elevate the basal activity. The results of the screening revealed that 7 mutations in helices II (S622A and T627A), III (A664S, A665S, T670A and N671A) and IV (T699A) partially abrogated the loss of responsiveness to agonist caused by T764W (Supplemental fig. 1 ). Thus, these residues are also involved in the modulation of the microenvironment around T764.
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Discussion
In the present study, we identified several novel CAM sites in the TMD of mGluR8 by systematic point mutation analyses based on the known activating variants of CaSR (Hu et al., 2005) . Among the CAM sites, the site at position 764 was remarkable, because mutation at this site caused prominent elevation of the basal activity (Table 1 ). In addition, we found that the amino acid residue at this position forms a specific pair with that at position 663, which is also a CAM site. In this section, we will discuss the mechanism of activation of mGluR deduced from the characterization of these CAMs.
T764 is presumably located in the middle of helix V, according to the 2D diagram of mGluR8 (Fig.1) . As might be expected from the position of T764, replacements of this residue with charged amino acids or proline (an alpha-helix breaker) caused loss of expression of functional proteins, whereas all the other mutants showed reasonable levels of expression. It was a surprise for us to find that all the expressed mutants showed significant elevation of the basal activity ( Fig.2a) , because the replacements included a wide variety of amino acids, from the smallest (glycine) to the largest (tryptophan). Even replacement by serine, which differs from threonine only by lacking one methyl group, resulted in a marked increase of constitutive activity (Fig.2a) . These results strongly suggested that the threonine residue at position 764 in helix V takes part in a specific interaction with amino acid residue(s) situated in a proximal transmembrane helix, thereby resulting in stabilization of the inactive state of mGluR8.
15/28
In order to identify residue(s) interacting with T764, we first searched for CAM sites by means of comprehensive alanine-scanning mutagenesis. We expected that the replacement of the residue(s) interacting with T764 would also cause elevation of the basal activity because it would disrupt the specific interaction with T764. Among the seven CAM sites we newly identified, we found that Y663 in the middle of helix III is the residue interacting with T764.
Considering the molecular characteristics of the tyrosine and threonine located at positions 764 and 663, it is expected that these two residues would have steric and electrostatic interactions with each other. Figure 4 shows a model in which T764 and Y663 constitute a signal mediator in the TMD of mGluR8. In the wild-type, these residues would form an activation switch which relays the agonist-induced structural change in the ECD to the cytoplasmic surface responsible for G protein activation (Fig.4a) . Thus, a drastic mutation such as T764W would disrupt the relay so as to make mGluR8 insensitive to agonist binding (Fig.4b) . In Y663A/T764W, the alanine substitution of Y663 relieves the steric and electrostatic hindrance caused by T764W, and as a result, the activation profile of the double mutant becomes similar to that of the wild-type.
The model in Figure 4 is the most straightforward interpretation of the present results, but we cannot exclude the possibility that mutations at the switch region such as T764W could induce a global conformational change throughout the receptor molecule which might break the functional coupling between ECD and the cytoplasmic G protein-interacting site. Moreover, other residues neighboring T764 or Y663 might be involved in this activation switch secondarily.
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In fact, some of the replacements of tyrosine at position 663 do not cause elevation of the basal activity, whereas all of the T764 replacements do (Fig.3d) .
These results suggest that, although Y663 is the primary residue interacting with T764, there are other residues that optimize the interaction between Y663 and T764. Regarding this point, it should be noted that the residues in mGluR5 and mGluR1 corresponding to Y663 form binding sites of MPEP and EM-TBPC, which are allosteric modulators of mGluR5 and mGluR1, respectively (Malherbe et al., 2003a; Malherbe et al., 2003b) . These facts emphasize the physiological significance of the activation switch identified in this study.
Several CAMs (T764A/W, Y663A/W, L667A, M787A and C791A) in TMD identified in this study resulted in an increase of affinity to agonist in ECD (Fig.   2b , Table 2 ), although these domains are separated. This could be explained by a simple two-state model (Samama et al., 1993) , where mGluR8 would be in thermal equilibrium between inactive and active states and affinity to agonist would be increased to some extent by CAMs, which shift the equilibrium to the active state. In contrast, no significant elevation was detected for other CAMs identified in this study (L625A, Y788A or T789A) ( Table 2) or CAMs in our previous studies (L621 or Q695) (Yamashita et al., 2004; Yamashita et al., 2008) .
Thus, mGluR could function via the equilibrium of not two but multiple conformational states.
In conclusion, the present results provide some novel insights about amino acid residues responsible for the regulation of mGluR activity. Especially, the interaction between Y663 in helix III and T764 in helix V constitutes one of The mutated residues corresponding to the activating mutation sites of CaSR are indicated by bold italic letters. T764 and the residues which were replaced by alanine (or serine) in the double mutation analysis are indicated by either black or gray shading. The residues whose substitution resulted in the recovery of responsiveness to agonist (which was abolished by T764W) are indicated by black shading. * indicates the residues whose substitution resulted in an increase of basal activity in our present and previous studies (Yamashita et al., 2004; Yamashita et al., 2008) . (c) The ability of double mutants to respond to agonist. Data are expressed as the rate of G protein activation ability with L-AP4 relative to that without it. * This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. 
